As of 2026-04-11, the EV/EBITDA ratio of Alligator Bioscience AB (ATORX.ST) is -0.59. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ATORX.ST's latest enterprise value is 64.44 mil SEK. ATORX.ST's TTM EBITDA according to its financial statements is -108.60 mil SEK. Dividing these 2 quantities gives us the above ATORX.ST EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.3x - 15.5x | 13.2x |
| Forward P/E multiples | 13.4x - 26.0x | 19.8x |
| Fair Price | (2.68) - (3.11) | (3.31) |
| Upside | -1657.2% - -1908.0% | -2024.4% |
| Date | EV/EBITDA |
| 2026-04-02 | -0.58 |
| 2026-04-01 | -0.58 |
| 2026-03-31 | -0.60 |
| 2026-03-30 | -0.56 |
| 2026-03-27 | -0.58 |
| 2026-03-26 | -0.59 |
| 2026-03-25 | -0.61 |
| 2026-03-24 | -0.62 |
| 2026-03-23 | -0.64 |
| 2026-03-20 | -0.63 |
| 2026-03-19 | -0.66 |
| 2026-03-18 | -0.72 |
| 2026-03-17 | -0.68 |
| 2026-03-16 | -0.68 |
| 2026-03-13 | -0.72 |
| 2026-03-12 | -0.77 |
| 2026-03-11 | -0.71 |
| 2026-03-10 | -0.77 |
| 2026-03-09 | -0.66 |
| 2026-03-06 | -0.71 |
| 2026-03-05 | -0.73 |
| 2026-03-04 | -0.70 |
| 2026-03-03 | -0.64 |
| 2026-03-02 | -0.70 |
| 2026-02-27 | -0.73 |
| 2026-02-26 | -0.71 |
| 2026-02-25 | -0.67 |
| 2026-02-24 | -0.66 |
| 2026-02-23 | -0.65 |
| 2026-02-20 | -0.66 |
| 2026-02-19 | -0.67 |
| 2026-02-18 | -0.66 |
| 2026-02-17 | -0.61 |
| 2026-02-16 | -0.61 |
| 2026-02-13 | -0.62 |
| 2026-02-12 | -0.69 |
| 2026-02-11 | -0.73 |
| 2026-02-10 | -0.78 |
| 2026-02-09 | -0.72 |
| 2026-02-06 | -0.63 |
| 2026-02-05 | -0.62 |
| 2026-02-04 | -0.61 |
| 2026-02-03 | -0.63 |
| 2026-02-02 | -0.66 |
| 2026-01-30 | -0.67 |
| 2026-01-29 | -0.68 |
| 2026-01-28 | -0.71 |
| 2026-01-27 | -0.72 |
| 2026-01-26 | -0.73 |
| 2026-01-23 | -0.76 |